Analysts at Jefferies initiated coverage on Cellectis SA (ADR) (NASDAQ: CLLS) with a Buy rating. The target price for Cellectis is set to $46. Cellectis shares closed at $32.59 on Friday.
Analysts at Leerink Swanninitiated coverage on Team...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.